Skip to search formSkip to main contentSkip to account menu

Exanta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
For decades, the standards of antithrombotic therapy have been heparin and coumarin compounds, primarily warfarin (1). Other… 
Review
2005
Review
2005
Atrial fibrillation is the most common sustained cardiac arrhythmia and the most frequently encountered cause of embolic stroke… 
Review
2004
Review
2004
Ximelagatran (Exanta™, AstraZeneca) is a novel oral direct thrombin inhibitor that inhibits the final step in the coagulation… 
2003
2003
The phase III trial EXPRESS was a randomised, double-blind comparison of two anticoagulant therapies used as prophylaxis against…